BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Galli F, Aguilera JV, Palermo B, Markovic SN, Nisticò P, Signore A. Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy. J Exp Clin Cancer Res 2020;39:89. [PMID: 32423420 DOI: 10.1186/s13046-020-01586-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Kwiecień I, Rutkowska E, Raniszewska A, Rzepecki P, Domagała-Kulawik J. Modulation of the immune response by heterogeneous monocytes and dendritic cells in lung cancer. World J Clin Oncol 2021; 12(11): 966-982 [PMID: 34909393 DOI: 10.5306/wjco.v12.i11.966] [Reference Citation Analysis]
2 Sanegre S, Eritja N, de Andrea C, Diaz-Martin J, Diaz-Lagares Á, Jácome MA, Salguero-Aranda C, García Ros D, Davidson B, Lopez R, Melero I, Navarro S, Ramon Y Cajal S, de Alava E, Matias-Guiu X, Noguera R. Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma. Front Cell Dev Biol 2021;9:670185. [PMID: 34150764 DOI: 10.3389/fcell.2021.670185] [Reference Citation Analysis]
3 Hassani H, Machado JAT, Avazzadeh Z, Safari E, Mehrabi S. Optimal solution of the fractional order breast cancer competition model. Sci Rep 2021;11:15622. [PMID: 34341390 DOI: 10.1038/s41598-021-94875-1] [Reference Citation Analysis]
4 Alvarez-Arellano L, Eguía-Aguilar P, Piña-Sánchez P, González-García N, Palma-Guzman A, Perezpeña-Diazconti M, Maldonado-Bernal C. High expression of Toll-like receptor 7 is a survival factor in pediatric medulloblastoma. Childs Nerv Syst 2021;37:3743-52. [PMID: 34480601 DOI: 10.1007/s00381-021-05347-w] [Reference Citation Analysis]
5 Guo Y, Liu Y, Wu W, Ling D, Zhang Q, Zhao P, Hu X. Indoleamine 2,3-dioxygenase (Ido) inhibitors and their nanomedicines for cancer immunotherapy. Biomaterials 2021;276:121018. [PMID: 34284200 DOI: 10.1016/j.biomaterials.2021.121018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Chen Y, Zhang C, Zou X, Yu M, Yang B, Ji CF, Gao SY, Li J, Liu B. Identification of macrophage related gene in colorectal cancer patients and their functional roles. BMC Med Genomics 2021;14:159. [PMID: 34120619 DOI: 10.1186/s12920-021-01010-0] [Reference Citation Analysis]
7 Agarwal P, Le DT, Boland PM. Immunotherapy in colorectal cancer. Adv Cancer Res 2021;151:137-96. [PMID: 34148613 DOI: 10.1016/bs.acr.2021.03.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
8 Vecchi L, Araújo TG, Azevedo FVPV, Mota STS, Ávila VMR, Ribeiro MA, Goulart LR. Phospholipase A2 Drives Tumorigenesis and Cancer Aggressiveness through Its Interaction with Annexin A1. Cells 2021;10:1472. [PMID: 34208346 DOI: 10.3390/cells10061472] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Akkın S, Varan G, Bilensoy E. A Review on Cancer Immunotherapy and Applications of Nanotechnology to Chemoimmunotherapy of Different Cancers. Molecules 2021;26:3382. [PMID: 34205019 DOI: 10.3390/molecules26113382] [Reference Citation Analysis]
10 Park EG, Pyo SJ, Cui Y, Yoon SH, Nam JW. Tumor immune microenvironment lncRNAs. Brief Bioinform 2021:bbab504. [PMID: 34891154 DOI: 10.1093/bib/bbab504] [Reference Citation Analysis]
11 Liberini V, Mariniello A, Righi L, Capozza M, Delcuratolo MD, Terreno E, Farsad M, Volante M, Novello S, Deandreis D. NSCLC Biomarkers to Predict Response to Immunotherapy with Checkpoint Inhibitors (ICI): From the Cells to In Vivo Images. Cancers (Basel) 2021;13:4543. [PMID: 34572771 DOI: 10.3390/cancers13184543] [Reference Citation Analysis]
12 Wojas-Krawczyk K, Paśnik I, Kucharczyk T, Wieleba I, Krzyżanowska N, Gil M, Krawczyk P, Milanowski J. Immunoprofiling: An Encouraging Method for Predictive Factors Examination in Lung Cancer Patients Treated with Immunotherapy. Int J Mol Sci 2021;22:9133. [PMID: 34502043 DOI: 10.3390/ijms22179133] [Reference Citation Analysis]
13 Mueller CG, Gaiddon C, Venkatasamy A. Current Clinical and Pre-Clinical Imaging Approaches to Study the Cancer-Associated Immune System. Front Immunol 2021;12:716860. [PMID: 34539653 DOI: 10.3389/fimmu.2021.716860] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wu H, Wang H, Jiang Z, Chen Y. Identification of Three Core Secretome Genes Associated with Immune Infiltration in High Tumor Mutation Burden Across 14 Major Solid Tumors. Int J Gen Med 2021;14:6755-67. [PMID: 34703282 DOI: 10.2147/IJGM.S333141] [Reference Citation Analysis]
15 Li N, Li Y, Zheng P, Zhan X. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Front Endocrinol (Lausanne) 2021;12:755805. [PMID: 34745015 DOI: 10.3389/fendo.2021.755805] [Reference Citation Analysis]
16 Chaudhari S, Dey Pereira S, Asare-Warehene M, Naha R, Kabekkodu SP, Tsang BK, Satyamoorthy K. Comorbidities and inflammation associated with ovarian cancer and its influence on SARS-CoV-2 infection. J Ovarian Res 2021;14:39. [PMID: 33632295 DOI: 10.1186/s13048-021-00787-z] [Reference Citation Analysis]
17 Budi HS, Ahmad FN, Achmad H, Ansari MJ, Mikhailova MV, Suksatan W, Chupradit S, Shomali N, Marofi F. Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen receptor (CAR) for tumor immunotherapy; recent progress. Stem Cell Res Ther 2022;13. [DOI: 10.1186/s13287-022-02719-0] [Reference Citation Analysis]
18 Jurj A, Pasca S, Braicu C, Rusu I, Korban SS, Berindan-Neagoe I. Focus on organoids: cooperation and interconnection with extracellular vesicles - is this the future of in vitro modeling? Semin Cancer Biol 2021:S1044-579X(21)00295-9. [PMID: 34896267 DOI: 10.1016/j.semcancer.2021.12.002] [Reference Citation Analysis]
19 Labbé RP, Vessillier S, Rafiq QA. Lentiviral Vectors for T Cell Engineering: Clinical Applications, Bioprocessing and Future Perspectives. Viruses 2021;13:1528. [PMID: 34452392 DOI: 10.3390/v13081528] [Reference Citation Analysis]
20 Liberini V, Laudicella R, Capozza M, Huellner MW, Burger IA, Baldari S, Terreno E, Deandreis D. The Future of Cancer Diagnosis, Treatment and Surveillance: A Systemic Review on Immunotherapy and Immuno-PET Radiotracers. Molecules 2021;26:2201. [PMID: 33920423 DOI: 10.3390/molecules26082201] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
21 Gavilán H, Avugadda SK, Fernández-Cabada T, Soni N, Cassani M, Mai BT, Chantrell R, Pellegrino T. Magnetic nanoparticles and clusters for magnetic hyperthermia: optimizing their heat performance and developing combinatorial therapies to tackle cancer. Chem Soc Rev 2021;50:11614-67. [PMID: 34661212 DOI: 10.1039/d1cs00427a] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Thaklaewphan P, Ruttanapattanakul J, Monkaew S, Buatoom M, Sookkhee S, Nimlamool W, Potikanond S. Kaempferia parviflora extract inhibits TNF-α-induced release of MCP-1 in ovarian cancer cells through the suppression of NF-κB signaling. Biomed Pharmacother 2021;141:111911. [PMID: 34328090 DOI: 10.1016/j.biopha.2021.111911] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Huang J, Gu Z, Xu Y, Jiang L, Zhu W, Wang W. CHI3L1 (Chitinase 3 Like 1) upregulation is associated with macrophage signatures in esophageal cancer. Bioengineered 2021;12:7882-92. [PMID: 34612767 DOI: 10.1080/21655979.2021.1974654] [Reference Citation Analysis]
24 Razaghi A, Poorebrahim M, Sarhan D, Björnstedt M. Selenium stimulates the antitumour immunity: Insights to future research. Eur J Cancer 2021;155:256-67. [PMID: 34392068 DOI: 10.1016/j.ejca.2021.07.013] [Reference Citation Analysis]
25 Barone A, d’Avanzo N, Cristiano MC, Paolino D, Fresta M. Macrophage-Derived Extracellular Vesicles: A Promising Tool for Personalized Cancer Therapy. Biomedicines 2022;10:1252. [DOI: 10.3390/biomedicines10061252] [Reference Citation Analysis]
26 Gampala S, Yang JY. Hedgehog Pathway Inhibitors against Tumor Microenvironment. Cells 2021;10:3135. [PMID: 34831357 DOI: 10.3390/cells10113135] [Reference Citation Analysis]
27 Bae IY, Choi W, Oh SJ, Kim C, Kim S. TIMP ‐1‐expressing breast tumor spheroids for the evaluation of drug penetration and efficacy. Bioengineering & Transla Med. [DOI: 10.1002/btm2.10286] [Reference Citation Analysis]
28 Zada S, Hwang JS, Ahmed M, Lai TH, Pham TM, Elashkar O, Kim DR. Cross talk between autophagy and oncogenic signaling pathways and implications for cancer therapy. Biochim Biophys Acta Rev Cancer 2021;1876:188565. [PMID: 33992723 DOI: 10.1016/j.bbcan.2021.188565] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Duan J, Lv G, Zhu N, Chen X, Shao Y, Liu Y, Zhao W, Shi Y. Multidimensional profiling depicts infiltrating immune cell heterogeneity in the tumor microenvironment of stage IA non‐small cell lung cancer. Thoracic Cancer. [DOI: 10.1111/1759-7714.14329] [Reference Citation Analysis]
30 Guven DC, Yildirim HC, Bilgin E, Aktepe OH, Taban H, Sahin TK, Cakir IY, Akin S, Dizdar O, Aksoy S, Yalcin S, Erman M, Kilickap S. PILE: a candidate prognostic score in cancer patients treated with immunotherapy. Clin Transl Oncol 2021;23:1630-6. [PMID: 33586122 DOI: 10.1007/s12094-021-02560-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Zhang J, Wang Z, Zhang H, Dai Z, Liang X, Li S, Zhang X, Liu F, Liu Z, Yang K, Cheng Q. Functions of RNF Family in the Tumor Microenvironment and Drugs Prediction in Grade II/III Gliomas. Front Cell Dev Biol 2022;9:754873. [DOI: 10.3389/fcell.2021.754873] [Reference Citation Analysis]
32 Hamilton MM, Mseeh F, McAfoos TJ, Leonard PG, Reyna NJ, Harris AL, Xu A, Han M, Soth MJ, Czako B, Theroff JP, Mandal PK, Burke JP, Virgin-Downey B, Petrocchi A, Pfaffinger D, Rogers NE, Parker CA, Yu SS, Jiang Y, Krapp S, Lammens A, Trevitt G, Tremblay MR, Mikule K, Wilcoxen K, Cross JB, Jones P, Marszalek JR, Lewis RT. Discovery of IACS-9779 and IACS-70465 as Potent Inhibitors Targeting Indoleamine 2,3-Dioxygenase 1 (IDO1) Apoenzyme. J Med Chem 2021;64:11302-29. [PMID: 34292726 DOI: 10.1021/acs.jmedchem.1c00679] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Bashash D, Zandi Z, Kashani B, Pourbagheri-Sigaroodi A, Salari S, Ghaffari SH. Resistance to immunotherapy in human malignancies: Mechanisms, research progresses, challenges, and opportunities. J Cell Physiol 2021. [PMID: 34498289 DOI: 10.1002/jcp.30575] [Reference Citation Analysis]
34 Gu H, Deng W, Zheng Z, Wu K, Sun F. CCL2 produced by pancreatic ductal adenocarcinoma is essential for the accumulation and activation of monocytic myeloid-derived suppressor cells. Immun Inflamm Dis 2021;9:1686-95. [PMID: 34525267 DOI: 10.1002/iid3.523] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Aló PL, Cicciarelli M, De Felice F, Quintiliani C, Corsi A, Polimeni A. Immunohistochemical Differences in Squamous Precancerous and Cancerous Lesions of the Oral Cavity and the Larynx: Preliminary Data. Applied Sciences 2021;11:2048. [DOI: 10.3390/app11052048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
36 Jarosz-Biej M, Smolarczyk R, Cichoń T, Drzyzga A, Czapla J, Urbaś Z, Pilny E, Matuszczak S, Wojcieszek P. Brachytherapy in a Single Dose of 10Gy as an "in situ" Vaccination. Int J Mol Sci 2020;21:E4585. [PMID: 32605154 DOI: 10.3390/ijms21134585] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Ahmad M, Dhasmana A, Harne PS, Zamir A, Hafeez BB. Chemokine Clouding and Liver Cancer Heterogeneity: Does it Impact Clinical Outcomes? Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.02.015] [Reference Citation Analysis]
38 Liu Y, Zhang J, Wang Z, Zhang X, Dai Z, Wu W, Zhang N, Liu Z, Zhang J, Luo P, Wen Z, Yu J, Zhang H, Yang T, Cheng Q. Identify the Prognostic and Immune Profile of VSIR in the Tumor Microenvironment: A Pan-Cancer Analysis. Front Cell Dev Biol 2022;10:821649. [DOI: 10.3389/fcell.2022.821649] [Reference Citation Analysis]
39 Fu Y, Saraswat AL, Monpara J, Patel K. Stromal disruption facilitating invasion of a 'nano-arsenal' into the solid tumor. Drug Discov Today 2021:S1359-6446(21)00496-7. [PMID: 34823002 DOI: 10.1016/j.drudis.2021.11.015] [Reference Citation Analysis]